ACQUISITIONS - Narrative (Details) $ / shares in Units, $ in Thousands			12 Months Ended
	Jul. 31, 2023 USD ($) contingent_value_right $ / shares	Oct. 27, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2025 USD ($) $ / shares	Dec. 31, 2024 USD ($) $ / shares
Acquestive Therapeutics, Inc
Business Acquisition [Line Items]
Intangible assets useful life (in years)		12 years
Payments for asset acquisition		$ 9,000
Asset acquisition, deferred payments		$ 6,000
Royalties to be paid on quarterly gross margin (as a percent)		10.00%
Spectrum
Business Acquisition [Line Items]
Business acquisition, fixed exchange ratio (in dollars per share) | $ / shares	$ 0.1783
Number of contingent value right | contingent_value_right	1
Business acquisition, contingent consideration, per share, maximum (in dollars per share) | $ / shares	$ 0.20
Intangible assets useful life (in years)	10 years
Business transaction costs associated with merger			$ 8,900
Spectrum | ROLVEDON
Business Acquisition [Line Items]
Business combination, contingent consideration arrangements, range of outcomes, value, high	$ 44,700
Spectrum | ROLVEDON | Forecast
Business Acquisition [Line Items]
Business acquisition, contingent consideration, per share, maximum (in dollars per share) | $ / shares				$ 0.10	$ 0.10
Business combination, contingent consideration arrangements, range of outcomes, value, high				$ 225,000	$ 175,000